Merck revenue falls after dramatic drop in sales of Covid antiviral treatment
Despite the drop in molnupiravir sales, Merck's revenue and adjusted earnings for Q1 2023 beat Wall Street's expectations.
LocalNews
0
99
Despite the drop in molnupiravir sales, Merck's revenue and adjusted earnings for Q1 2023 beat Wall Street's expectations.
